Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sefora Conti"'
Autor:
Sefora Conti, Valeria Venturini, Adrià Cañellas-Socias, Carme Cortina, Juan F. Abenza, Camille Stephan-Otto Attolini, Emily Middendorp Guerra, Catherine K. Xu, Jia Hui Li, Leone Rossetti, Giorgio Stassi, Pere Roca-Cusachs, Alba Diz-Muñoz, Verena Ruprecht, Jochen Guck, Eduard Batlle, Anna Labernadie, Xavier Trepat
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Colorectal cancer (CRC) tumors are composed of heterogeneous and plastic cell populations, including a pool of cancer stem cells that express LGR5. Whether these distinct cell populations display different mechanical properties, and how thes
Externí odkaz:
https://doaj.org/article/f3eda4b90df041b09e2517b0f47ce22e
Autor:
Sefora Conti MSc, Akiva Vexler MD, PhD, Lior Hagoel MSc, Lital Kalich-Philosoph PhD, Benjamin W. Corn MD, Nir Honig, Natan Shtraus MSc, Yaron Meir BSc, Ilan Ron MD, PhD, Isaac Eliaz MD, Shahar Lev-Ari PhD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Background: Radiotherapy is one of the primary therapies for localized prostatic carcinoma. Therefore, there is an emerging need to sensitize prostatic cancer cells to chemotherapy/radiotherapy. Modified citrus pectin (MCP) is an effective inhibitor
Externí odkaz:
https://doaj.org/article/6b529b2b44f5404c8f466bc8bb08e762
Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Autor:
Sefora Conti, Akiva Vexler, Liat Edry-Botzer, Lital Kalich-Philosoph, Benjamin W Corn, Natan Shtraus, Yaron Meir, Lior Hagoel, Alexander Shtabsky, Sylvia Marmor, Gideon Earon, Shahar Lev-Ari
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0198627 (2018)
Glioblastoma multiforme (GBM) is the most common and most aggressive subtype of malignant gliomas. The current standard of care for newly diagnosed GBM patients involves maximal surgical debulking, followed by radiation therapy and temozolomide chemo
Externí odkaz:
https://doaj.org/article/7e38bf79c3c1450ea55fa7961f355344
Autor:
Patricia González‐Callejo, Petra Gener, Zamira V. Díaz‐Riascos, Sefora Conti, Patricia Cámara‐Sánchez, Roger Riera, Sandra Mancilla, Miguel García‐Gabilondo, Vicente Peg, Diego Arango, Anna Rosell, Anna Labernadie, Xavier Trepat, Lorenzo Albertazzi, Simó Schwartz, Joaquin Seras‐Franzoso, Ibane Abasolo
Publikováno v:
International Journal of Cancer, 152(10), 2153-2165. Wiley-Liss Inc.
Tumor secreted extracellular vesicles (EVs) are potent intercellular signaling platforms. They are responsible for the accommodation of the premetastatic niche (PMN) to support cancer cell engraftment and metastatic growth. However, complex cancer ce
Autor:
Adrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona, Sergio Palomo-Ponce, Eoghan J. Mulholland, Gemma Turon, Lidia Mateo, Sefora Conti, Olga Roman, Marta Sevillano, Felipe Slebe, Diana Stork, Adrià Caballé-Mestres, Antonio Berenguer-Llergo, Adrián Álvarez-Varela, Nicola Fenderico, Laura Novellasdemunt, Laura Jiménez-Gracia, Tamara Sipka, Lidia Bardia, Patricia Lorden, Julien Colombelli, Holger Heyn, Xavier Trepat, Sabine Tejpar, Elena Sancho, Daniele V. F. Tauriello, Simon Leedham, Camille Stephan-Otto Attolini, Eduard Batlle
Publikováno v:
Nature, 611, 603-613
Nature, 611, 7936, pp. 603-613
Nature, 611, 7936, pp. 603-613
Around 30-40% of patients with colorectal cancer (CRC) undergoing curative resection of the primary tumour will develop metastases in the subsequent years1. Therapies to prevent disease relapse remain an unmet medical need. Here we uncover the identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8021ef7ef986ce88ddea0394953659e3
http://hdl.handle.net/2445/191051
http://hdl.handle.net/2445/191051
Autor:
Adrià, Cañellas-Socias, Carme, Cortina, Xavier, Hernando-Momblona, Sergio, Palomo-Ponce, Eoghan J, Mulholland, Gemma, Turon, Lidia, Mateo, Sefora, Conti, Olga, Roman, Marta, Sevillano, Felipe, Slebe, Diana, Stork, Adrià, Caballé-Mestres, Antonio, Berenguer-Llergo, Adrián, Álvarez-Varela, Nicola, Fenderico, Laura, Novellasdemunt, Laura, Jiménez-Gracia, Tamara, Sipka, Lidia, Bardia, Patricia, Lorden, Julien, Colombelli, Holger, Heyn, Xavier, Trepat, Sabine, Tejpar, Elena, Sancho, Daniele V F, Tauriello, Simon, Leedham, Camille Stephan-Otto, Attolini, Eduard, Batlle
Publikováno v:
Nature. 611(7936)
Around 30-40% of patients with colorectal cancer (CRC) undergoing curative resection of the primary tumour will develop metastases in the subsequent years
Publikováno v:
Methods in Molecular Biology ISBN: 9781071607787
In many solid tumors, collective cell invasion prevails over single-cell dissemination strategies. Collective modes of invasion often display specific front/rear cellular organization, where invasive leader cells arise from cancer cell populations or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1e0daa7b7b081e134afa2d5e1ee1163
https://doi.org/10.1007/978-1-0716-0779-4_19
https://doi.org/10.1007/978-1-0716-0779-4_19
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2179
In many solid tumors, collective cell invasion prevails over single-cell dissemination strategies. Collective modes of invasion often display specific front/rear cellular organization, where invasive leader cells arise from cancer cell populations or
Autor:
Lital Kalich-Philosoph, Yaron Meir, Shahar Lev-Ari, Liat Edry-Botzer, Akiva Vexler, Sylvia Marmor, Natan Shtraus, Gideon Earon, Sefora Conti, Alexander Shtabsky, Lior Hagoel, Benjamin W. Corn
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0198627 (2018)
PLoS ONE
PLoS ONE
Glioblastoma multiforme (GBM) is the most common and most aggressive subtype of malignant gliomas. The current standard of care for newly diagnosed GBM patients involves maximal surgical debulking, followed by radiation therapy and temozolomide chemo
Autor:
Ben Koren, Natan Shtraus, Akiva Vexler, Sefora Conti, Nir Honig, Yaron Meir, Isaac Eliaz, Ilan G. Ron, Shahar Lev-Ari
Publikováno v:
Cancer Research. 75:5555-5555
Radio-resistance is a major cause of decreasing the efficiency of radiotherapy for prostate cancer. Modified citrus pectin (MCP) has been previously shown to demonstrate anti-proliferative and anti-metastatic activity in prostate cancer cells. Howeve